Daiichi, Eisai Look Beyond Japan To Expanded Markets In Southeast Asia (Japan)
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and Eisai are reaching beyond their Japan bases into other Asian markets to seek faster growth than they are seeing at home. Daiichi is looking to India as a good market for some of its flagship products, beginning in the spring, and is hiring a 100-person sales force, but Taiwan and other Asian markets also are in Daiichi plans. Eisai plans drug trials in China where it hopes to tap into a huge market, beginning with one for hepatitis B. Also in Eisai plans are member countries of the Association of Southeast Asian Nations where Eisai is looking for a 20 percent annual sales increase. (Click here for more - may require a subscription